Science Explorer Back to mapMap
Discussion
Researcher · New York Blood Center · United States

Larry L. Luchsinger

Larry L. Luchsinger publishes mostly in Infectious Diseases, Hematology and Molecular Biology, on topics such as SARS-CoV-2 and COVID-19 Research, Hematopoietic Stem Cell Transplantation and COVID-19 Clinical Research Studies.

ORCID 0000-0002-0063-1764 OpenAlex
World rank
#639,294
of 7,710,434 ranked researchers
Rank in United States
#218,068
of 1,627,098
Works
56
Citations
3.9k
Citations per work
69.7
h-index
20
i10-index 28Top 24% in Infectious Diseases
Larry L. Luchsinger

What does Larry L. Luchsinger research?

Larry L. Luchsinger's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (7%).

Health Sciences: 31 works · 54.6% of their workMedicine: 31 works · 54.6% of their workInfectious Diseases: 16 works · 28.3% of their workHematology: 10 works · 17.1% of their workGenetics: 3 works · 5.9% of their workPhysiology: 2 works · 3.3% of their workEverything else: 13 works · 23.7% of their workLife Sciences: 12 works · 21.7% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 15.1% of their workMolecular Biology: 8 works · 15.1% of their workImmunology and Microbiology: 4 works · 6.6% of their workImmunology: 4 works · 6.6% of their workTHEIR WORKLarry L.Luchsinger56works
Life Sciences22%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3154.6%
  2. Everything else1323.7%
    1. Biochemistry, Genetics and Molecular Biology815.1%
    2. Immunology and Microbiology46.6%
  1. 1Infectious Diseases28% of their works
  2. 2Hematology17% of their works
  3. 3Molecular Biology15% of their works
  4. 4Immunology7% of their works
  5. 5Genetics6% of their works
  6. 6Physiology3% of their works

Research topics

Which keywords describe Larry L. Luchsinger's research?

The keywords of their largest research topics: SARS-CoV-2, ACE2 Receptor, Pandemic, Hematopoietic Stem Cells, Vaccine, Mesenchymal Stem Cells, Coronavirus and spike protein.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. SARS-CoV-2393 topics
  2. ACE2 Receptor302 topics
  3. Pandemic302 topics
  4. Hematopoietic Stem Cells242 topics
  5. Vaccine222 topics
  6. Mesenchymal Stem Cells212 topics
  7. Coronavirus181 topic
  8. spike protein181 topic
  9. Bone Marrow Niche161 topic
  10. Epidemiology162 topics
  11. Graft-versus-Host Disease161 topic
  12. Clinical Characteristics121 topic
  13. Thrombosis121 topic
  14. COVID-1991 topic
  15. Diagnostics91 topic
  16. AML81 topic
  17. Acute Myeloid Leukemia81 topic
  18. Mitochondria51 topic
  19. Multipotent51 topic
  20. Reactive Oxygen Species51 topic
  21. Regeneration51 topic
  22. Norovirus41 topic
  23. Rotavirus41 topic

Where does Larry L. Luchsinger work?

Larry L. Luchsinger's main affiliation in the publication record is New York Blood Center, United States.

How many publications and citations does Larry L. Luchsinger have?

OpenAlex counts 56 works and 3,903 citations for Larry L. Luchsinger, an h-index of 20, ranking #639,294 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Larry L. Luchsinger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.